Views

CrossRef citations to date

Altmetric

Research Article

A novel chromatin regulator signature predicts the prognosis, clinical features and immunotherapy of colon cancer

Xiaopeng Li1 Department of General Surgery, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, Shaanxi, 710061, China

https://orcid.org/0000-0002-1738-0498 View further author information

Xiongwei Huo1 Department of General Surgery, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, Shaanxi, 710061, ChinaView further author information

Chenye Zhao1 Department of General Surgery, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, Shaanxi, 710061, ChinaView further author information

Zilu Chen1 Department of General Surgery, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, Shaanxi, 710061, ChinaView further author information

Zhengshui Xu2 Department of Thoracic Surgery, The Second Affiliated Hospital of Xi’an Jiaotong University, Xi’an, Shaanxi, 710004, ChinaView further author information

Junhui Yu1 Department of General Surgery, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, Shaanxi, 710061, ChinaCorrespondence[email protected]
View further author information

Xuejun Sun1 Department of General Surgery, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, Shaanxi, 710061, ChinaCorrespondence[email protected]
View further author information

show all

A novel chromatin regulator signature predicts the prognosis, clinical features and immunotherapy of colon cancer

Supplemental Figure 1

Supplemental Image 1

Supplemental Image 2

Supplemental Image 3

Supplemental Image 4

Supplemental Image 5

Supplemental Image 6

Supplemental Image 7

Supplemental Image 8

Supplemental Image 9

Supplemental Image 10

Supplemental Table 1

Supplemental Table 2

Supplemental Table 3

Supplemental Table 4

Supplemental Table 5

Supplemental Table 6

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

A novel chromatin regulator signature predicts the prognosis, clinical features and immunotherapy of colon cancer

Supplemental Figure 1

Supplemental Image 1

Supplemental Image 2

Supplemental Image 3

Supplemental Image 4

Supplemental Image 5

Supplemental Image 6

Supplemental Image 7

Supplemental Image 8

Supplemental Image 9

Supplemental Image 10

Supplemental Table 1

Supplemental Table 2

Supplemental Table 3

Supplemental Table 4

Supplemental Table 5

Supplemental Table 6

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date